Opportunity Information: Apply for PAR 22 226

The NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award is an NIH training-focused grant opportunity (R25; independent clinical trial not allowed) run by the National Institute on Aging (NIA). Its core aim is to build and strengthen entrepreneurial training programs that help scientists translate aging-related research into real-world products, services, and solutions. Rather than funding a traditional research project, this program is meant to support structured training and immersion experiences that expand career-ready skills, especially for people who may pursue paths beyond the standard academic research track.

The program is geared toward developing entrepreneurship-oriented curricula and experiences for graduate students and postdoctoral researchers, along with early-career scientists holding masters, Ph.D., or Dr.P.H. degrees. The training focus must align with NIA's mission areas, which include aging biology, geroscience, age-related clinical and social/behavioral research, and Alzheimer’s disease and related dementias (often referenced as AD). The overarching goal is to broaden trainees' skillsets so they can navigate a wider set of careers, including roles in industry, startups, venture creation, technology transfer, commercialization, product development, regulatory science, and other innovation-oriented settings connected to aging and AD.

This opportunity is identified as PAR-22-226 and falls under a discretionary grant mechanism in the health funding activity category (CFDA 93.866). The award ceiling is listed at $250,000, indicating the maximum amount that may be provided under the terms of the opportunity (exact budgets, project periods, and allowable cost structures typically depend on NIH and FOA-specific guidance, but the ceiling provides a practical cap for planning). The original closing date is October 17, 2024, which signals the last date applications were accepted under the listed schedule for that cycle.

A notable boundary of the program is embedded in the title: "Independent Clinical Trial Not Allowed." In practical terms, applicants should not propose an independent clinical trial as the core activity under this R25. The emphasis is on training program development and implementation, not running clinical trials, and applicants are expected to keep proposed activities within NIH's definition of allowable training and educational program work for this mechanism.

Eligibility is broad across U.S.-based organizations and includes many types of government entities and institutions. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (when not institutions of higher education); for-profit organizations other than small businesses; and small businesses, among others. The opportunity explicitly highlights additional eligible organizational categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions, reflecting a strong openness to varied institutional settings that can deliver effective entrepreneurship training.

At the same time, the announcement is clear about restrictions related to foreign participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined in the NIH Grants Policy Statement) are not allowed. In short, the applicant organization and the supported program components must be U.S.-based without foreign components.

Overall, this REDI R25 opportunity is best understood as capacity-building support for entrepreneurship education and immersion programs tied to aging and Alzheimer’s-related science. Competitive proposals will typically be those that can convincingly show a well-designed training structure, meaningful experiential learning opportunities, and a clear pathway for trainees to gain practical skills for innovation and commercialization, all while staying within the non-clinical-trial, training-centric boundaries of the R25 mechanism.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2022-08-24.
  • Applicants must submit their applications by 2024-10-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 22 226

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Entrepreneurs

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required)

Previous opportunity: Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 22 226

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 22 226) also looked into and applied for these:

Funding Opportunity
NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) Apply for PAR 22 227

Funding Number: PAR 22 227
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed) Apply for PAR 22 235

Funding Number: PAR 22 235
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) Apply for PAR 23 027

Funding Number: PAR 23 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32) Apply for RFA HS 22 010

Funding Number: RFA HS 22 010
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed) Apply for RFA AG 23 018

Funding Number: RFA AG 23 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $16,200,000
Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed) Apply for PAR 22 204

Funding Number: PAR 22 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) Apply for RFA OD 22 013

Funding Number: RFA OD 22 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Apply for PAR 22 225

Funding Number: PAR 22 225
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) Apply for PAR 22 250

Funding Number: PAR 22 250
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Apply for PA 22 251

Funding Number: PA 22 251
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Limited Competition: The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24 Clinical Trial Not Allowed) Apply for RFA HG 22 020

Funding Number: RFA HG 22 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) Apply for PAR 22 254

Funding Number: PAR 22 254
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space Clinical Resource (ACR) (U24 Clinical Trial Not Allowed) Apply for RFA HG 22 021

Funding Number: RFA HG 22 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) Apply for RFA MH 22 270

Funding Number: RFA MH 22 270
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (U43/U44 - Clinical Trail Not Allowed) Apply for RFA TR 22 032

Funding Number: RFA TR 22 032
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 031

Funding Number: RFA NS 22 031
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Data Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - DCC) (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 030

Funding Number: RFA NS 22 030
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,300,000
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) Apply for RFA MH 22 271

Funding Number: RFA MH 22 271
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 22 241

Funding Number: PAR 22 241
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed) Apply for RFA TR 22 031

Funding Number: RFA TR 22 031
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 226", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: